Recently stock market analysts updated their outstanding price targets on shares of Evolent Health, Inc (NYSE:EVH).
08/05/2016 – Evolent Health, Inc had its “outperform” rating reiterated by analysts at FBR Capital Markets. They now have a USD 26 price target on the stock.
07/26/2016 – Jefferies began new coverage on Evolent Health, Inc giving the company a “buy” rating. They now have a USD 28 price target on the stock.
07/13/2016 – Evolent Health, Inc had its “outperform” rating reiterated by analysts at Leerink Swann. They now have a USD 20 price target on the stock.
03/14/2016 – Evolent Health, Inc had its “overweight” rating reiterated by analysts at JP Morgan. They now have a USD 19 price target on the stock.
02/26/2016 – Evolent Health, Inc had its “buy” rating reiterated by analysts at Canaccord Genuity. They now have a USD 22 price target on the stock. For the full article click here
from health IT caucus http://ift.tt/2dsLBZn
via IFTTT
No comments:
Post a Comment